Abbott Laboratories (ABT) reports robust earnings growth and margin expansion, driven by medical devices, despite headwinds ...

The Motley Fool. DATE Thursday, July 17, 2025 at 9 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer — Robert ...

Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...

Abbott Laboratories (NYSE:ABT) Q4 2023 Earnings Conference Call January 24, 2024 9:00 AM ETCompany Participants. Mike Comilla - Vice President, Investor Relations Robert Ford - Chairman and Chief ...

Barclays analyst Matt Miksic maintained an Overweight rating and increased the price target from $158 to $159 on April 17, ...

"Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS growth, significantly ...

ABBOTT PARK, Ill., June 25, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its second-quarter 2021 financial results on Thursday, July 22, 2021, before the market opens. The announcement ...

Q2 2025 Results Conference Call July 17, 2025 9:00 AM ETCompany ParticipantsMichael Comilla - Vice President of ...

ABT earnings call for the period ending June 30, 2024. The Motley Fool. Abbott Laboratories (ABT) Q2 2024 Earnings Call Transcript. ... Should you invest $1,000 in Abbott Laboratories right now?

ABT earnings call for the period ending December 31, 2023. ... Abbott Laboratories (NYSE: ABT) Q4 2023 Earnings Call Jan 24, 2024, 9:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers.

Abbott Laboratories reports earnings inline with expectations. Reported EPS is $1.19 EPS, expectations were $1.19. ... Welcome to Abbott’s Fourth Quarter 2023 Earnings Conference Call.

Abbott Laboratories beats earnings expectations. Reported EPS is $1.14, expectations were $1.1. Operator: Good morning, and thank you for standing by. Welcome to Abbott’s Third Quarter 2023 ...